Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New pulse oximeter feature tested for blood flow accuracy

NCT ID NCT06586918

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study looked at whether a new feature on a pulse oximeter (called perfusion index) can accurately measure blood flow in the skin. Researchers compared it to a laser Doppler device in 32 healthy adults. The goal was to see if the two methods agree, which could help doctors monitor blood flow more easily in the future.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

32 people

The number who actually took part.

Started

Sep 2024

Finished

Sep 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Healthy Male or Female volunteers age ≥18 years, weighing greater than 40kgs.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Subjects ≥18 years of age 2. Subject is able to participate for the duration of the study 3. Subject is willing to sign an informed consent 4. Subject weighs \>40kg Exclusion Criteria: 1. Previous injury or trauma to fingers or hands that may change blood flow or vascular supply and affect the ability to test sensors 2. Physiologic abnormalities that prevent proper application of pulse oximetry sensor 3. Severe contact allergies that cause a reaction to standard adhesive materials such as those found in medical sensors and electrodes. 4. Raynaud Syndrome 5. Repeated systolic blood pressure \> 140mmHg -

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Perfusion; complications are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Medtronic Clinical Physiology Lab

    Denver, Colorado, 80218, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.